Effects of pentastarch-deferoxamine conjugate on lung injury after cardiopulmonary bypass

Circulation

Volumn 94, Issue 9 SUPPL., 1996, Pages

  Stamler, Alon ^a   Wang, Steven Y ^a   Aguirre, Douglas E ^a   Sellke, Frank W ^a   Johnson, Robert G ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

cardiopulmonary bypass; deferoxamine; edema; lung; pentastarch

Indexed keywords

DEFEROXAMINE; HETASTARCH; OXYGEN RADICAL; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLEARANCE; CONTROLLED STUDY; DRUG CONJUGATION; HEMODYNAMICS; ISCHEMIA; LUNG INJURY; LYMPH FLOW; NONHUMAN; PRIORITY JOURNAL; SHEEP; WEIGHT GAIN;

ANIMALS; CAPILLARIES; CARDIOPULMONARY BYPASS; DEFEROXAMINE; HEMODYNAMIC PROCESSES; HETASTARCH; IRON CHELATING AGENTS; LUNG; OXYGEN; SHEEP;

EID: 10244242551     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Friedman M, Sellke FW, Wang SY, Weintraub RM, Johnson RG. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation. 1994;90(pt 2):II-262-II-268.
2. Royston D, Fleming JS, Desai JB, Westaby S, Taylor KM. Increased production of peroxidation products associated with cardiac operation. J Thorac Cardiovasc Surg. 1986;91:759-766.
3. Zweier JL, Kuppusamy P, Lutty GA. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci U S A. 1988;85:4046-4050.
4. Sellke FW, Shafique T, Ely DL, Weintraub RM. Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals. Circulation. 1993;88(pt 2):II-395-II-400.
5. Koike K, Albertine KH, Staub NC. Intrathoracic sources of caudal mediastinal lymph node efferent lymph in sheep. J Appl Physiol. 1986;60:80-84.
6. Sellke FW, Wang SY, Friedman M, Harada K, Edelman ER, Grossman W, Simons M. Basic FGF enhances endothelium-dependent relaxation of collateral-perfused coronary microcirculation. Am J Physiol. 1994;267:H1303-H1311.
7. Brazeal BA, Honeycutt D, Traber LD, Toole JG, Herndon DN, Traber DL. Pentafraction for superior resuscitation of the ovine thermal burn. Crit Care Med. 1995;23:332-339.
8. Vandermeer TJ, Menconi MJ, O'Sullivan BP, Larkin VA, Wang H, Kradin RL, Fink MP. Bacterial/permeability-increasing protein ameliorates acute lung injury in porcine endotoxemia. J Appl Physiol. 1994;76:2006-2014.
9. Friedman M, Wang SY, Sellke FW, Franklin A, Weintraub RM, Johnson RG. Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition. Ann Thorac Surg. 1995;59:598-603.
10. Bando K, Pillai R, Cameron DE, Brawn JD, Winkelstein JA, Hutchins GM, Reitz BA, Baumgartner WA. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1990;99:873-877.
11. Tate RM, Repine JE. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis. 1983;128:552-559.
12. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxines. N Engl J Med. 1981;304:479-503.
13. Ratliff NB, Young GW Jr, Hackel DB, Mikat E, Wilson JW. Pulmonary injury secondary to extracorporeal circulation: an ultrastructural study. J Thorac Cardiovasc Surg. 1973;65:425-432.
14. Menasch P, Antebi H, Alcindor LG, Teiger E, Perez G, Giudicelli Y, Nordman R, Piwnica A. Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans. Circulation. 1990;82(suppl IV):IV-390-IV-396.
15. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest. 1982;47:412-426.
16. Maruyama M, Pieper GM, Kalyanaraman B, Hallaway PE, Hedlund BE, Gross GJ. Effects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs. J Cardiovasc Pharmacol. 1991; 17:166-175.
17. Bolli R, Patel BS, Jeroudi MO, Li X, Triana JF, Lai EK, McCay PB. Iron mediated radical reactions upon reperfusion contribute to myocardial 'stunning.' Am J Physiol. 1990;259:H1901-H1911.
18. Williams RE, Zweier JL, Flaherty JT. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation. 1991;83:1006-1014.
19. Menasch P, Grousset C, Gauduel Y, Mouas C, Piwnica A. Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Circulation. 1987;76(suppl V):V-180-V-185.
20. Fantini GA, Yoshioka T. Deferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle. Am J Physiol. 1993;264:H1953-H1959.
21. Monta K, Ihnken K, Buckberg GD, Sherman MP, Young HH. Studies of hypoxemic/reoxygenation injury without aortic clamping: the role of iron-catalyzed pathway: deferoxamine. J Thorac Cardiovasc Surg. 1995;110:1190-1199.
22. Hallaway PE, Eaton JW, Panter SS, Hedlund BE. Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc Natl Acad Sci U S A. 1989;86:10108-10112.
23. London MJ, Franks M, Verrier ED, Merrick SH, Levin J, Mangano DT. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution: a randomized trial. J Thorac Cardiovasc Surg. 1992;104:284-296.
24. Myers GA, Conhaim RL, Rosenfeld DJ, Harms BA. Effects of pentafraction and hetastarch plasma expansion on lung and soft tissue transvascular fluid filtration. Surgery. 1995;117:340-349.
25. Sade RM, Stroud MR, Crawford FA Jr, Kratz JM, Dearing JP, Bartles DM. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1985;89:713-722.
26. Öhqvist G, Settergren G, Lundberg S. Pulmonary oxygenation, central haemodynamics and glomerular filtration following cardiopulmonary bypass with colloid or non colloid priming solution. Scand J Thorac Cardiovasc Surg. 1981;15:257-262.